Molecular Breast Imaging-guided Percutaneous Biopsy of Breast Lesions: A New Frontier on Breast Intervention

By December 1, 2020 MBI

Beatriz E Adrada, MD, Tanya Moseley, MD, S Cheenu Kappadath, PhD, Gary J Whitman, MD, Gaiane M Rauch, MD, PhD

Abstract: Molecular breast imaging (MBI) is an increasingly recognized nuclear medicine imaging modality to detect breast lesions suspicious for malignancy. Recent advances have allowed the development of tissue sampling of MBI-detected lesions using a single-headed camera (breast-specific gamma imaging system) or a dual-headed camera system (MBI system). In this article, we will review current indications of MBI, differences of the two single- and dual-headed camera systems, the appropriate selection of biopsy equipment, billing considerations, and radiation safety. It will also include practical considerations and guidance on how to integrate MBI and MBI-guided biopsy in the current breast imaging workflow.

Full Article in Journal of Breast Imaging, Volume 2, Issue 5, September/October 2020, Pages 484–491